Self-Injected Antiplatelet for Acute MI Enters Phase 3 Testing Self-Injected Antiplatelet for Acute MI Enters Phase 3 Testing

The SOS-AMI study will test the ' truly innovative ' idea for patients to self-inject an antiplatelet early after heart attack symptoms occur.Medscape Medical News

Source: Medscape FamilyMedicine Headlines - June 30, 2021 Category: Primary Care Tags: Cardiology Live Webcast Source Type: news